Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Deffered Revenue (2016 - 2022)

Veracyte's Non-Current Deffered Revenue history spans 10 years, with the latest figure at $278000.0 for Q1 2022.

  • For Q1 2022, Non-Current Deffered Revenue fell 62.78% year-over-year to $278000.0; the TTM value through Mar 2022 reached $278000.0, down 62.78%, while the annual FY2021 figure was $343000.0, 58.62% down from the prior year.
  • Non-Current Deffered Revenue for Q1 2022 was $278000.0 at Veracyte, down from $343000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $4.1 million in Q1 2018 and bottomed at $278000.0 in Q1 2022.
  • The 4-year median for Non-Current Deffered Revenue is $788000.0 (2020), against an average of $1.9 million.
  • The largest annual shift saw Non-Current Deffered Revenue fell 6.36% in 2018 before it crashed 62.78% in 2022.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $3.9 million in 2018, then crashed by 78.74% to $829000.0 in 2020, then plummeted by 58.62% to $343000.0 in 2021, then decreased by 18.95% to $278000.0 in 2022.
  • Per Business Quant, the three most recent readings for VCYT's Non-Current Deffered Revenue are $278000.0 (Q1 2022), $343000.0 (Q4 2021), and $552000.0 (Q3 2021).